Skip to main content
Menu
US

HTRF Human IL-15 Detection Kit, 500 Assay Points

The HTRF Human IL-15 kit is designed for the quantification of human IL-15 release within cell supernatants.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Feature Specification
Application Protein Quantification
Sample Volume 16 µL

The HTRF Human IL-15 kit is designed for the quantification of human IL-15 release within cell supernatants.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Product Variants
Unit Size: 500 Assay Points
Part #:
62HIL15PEG
List Price
USD 1,103.00
Unit Size: 10,000 Assay Points
Part #:
62HIL15PEH
List Price
USD 10,290.00

Overview

Human Interleukin 15 (IL-15) is a cytokine that is initially produced as a precursor that matures into a 114-amino acid glycoprotein. IL-15 is generated by multiple tissues, including the placenta, skeletal muscle, kidney, lung, heart, and monocytes/macrophages. IL-15 acts mainly on T and B cells and is a key cytokine in the development, proliferation, and survival of natural killer cells.

IL-15 binds with high affinity to the IL-15 receptor α and forms a complex with the α and γ chains of the IL-2 receptor for signal transduction. It can regulate inflammatory responses and activate NK cells during immune responses. IL-15 signaling has become a focus of interest for therapeutic interventions, especially in autoimmune diseases such as inflammatory bowel disease, systemic lupus erythematosus, inflammatory synovitis, psoriasis, diabetes mellitus, asthma bronchiale, rheumatoid arthritis, and T-cell leukemia.

Specifications

Application
Protein Quantification
Brand
HTRF
Detection Modality
HTRF
Product Group
Kit
Sample Volume
16 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Cytokines
Target Species
Human
Technology
TR-FRET
Unit Size
500 Assay Points

Video gallery

How it works

Assay principle

Cell supernatant, sample, or standard is dispensed directly into the assay plate for the detection by HTRF® reagents (384-well low-volume white plate or Revvity low-volume 96-well plate in 20 µl). The antibodies labeled with the HTRF donor and acceptor are pre-mixed and added in a single dispensing step, to further streamline the assay procedure. The assay can be run in up to a 1536-well format by simply resizing each addition volume proportionally.

Principle of the HTRF Human IL15 assay

 

Assay details

Standard curve

The IL-15 standard curve is generated in the assay Diluent 5, provided in the kit.

HTRF Human IL-15 standard curve
Assay specifications
Sample size 16 µL
Final assay volume 20 µL
Kit components Lyophilized standard, frozen detection antibodies, buffers & protocol
LOD & LOQ (in Diluent) 4 pg/mL & 10 pg/mL
LOD & LOQ (in RPMI +10%FCS) 8 & 10 pg/mL
LOD & LOQ (in DMEM +10%FCS) 16 & 20 pg/mL
Range 33.8 – 5000 pg/mL
Time to result Overnight at RT
Correspondance to I.S. NIBSC (95/554) value (IU/mL) = 0,013 x HTRF hIL-15 value (pg/mL)
Species Human only

 

Analytical performance

Intra and inter assay

Intra-assay (n=24)

Sample

Mean [IL15] (pg/mL)

CV

1

97

5%

2

985

5%

3

2 353

4%

 

Mean CV

5%

Each of the 3 samples was measured 24 times, and the % CV was calculated for each sample.

Inter-assay (n=4)

Sample

Mean [IL15] (pg/mL)

CV

1

78

 

2

411

 

3

2 174

6%5%4%

 

Mean CV

5%

Each of the samples was measured in 3 independent experiments (3 days), and the % CV was calculated for each sample.

Dilutional linearity

The excellent recovery percentages obtained from these experiments show the good dilution linearity of the assay. Samples were HUT-102 supernatants serially diluted in RPMI medium.

Dilution factor

[IL-15] expected (pg/mL)

[IL-15] measured (pg/mL)

Dilution recovery

Neat

-

153

 

2

76.5

70

92%

4

38.3

34.8

92%

8

19.1

19.8

105%

16

9.6

10.2

105%

 

Mean CV

 

98.5%

 
Antigen spike recovery

Recombinant cytokine was added to HUT-102 supernatant samples, and the measured response was compared to the calculated expected values. The 100% of recovery indicates similar measurements of cytokine from sample and the kit standard.

Sample

[IL-15] spiked sample (pg/mL)

 

[IL-15] standard (pg/mL)

Expected (pg/mL)

Measured (pg/mL)

Recovery

1

400

144

544

511.2

94%

72

472

437

93%

2

100

144

244

254.2

104%

72

172

169

98%

 

Mean CV

 

 

 

97.3%

 

Cross-reactivities

Cross reactivities were assessed using recombinant proteins from the IL2 cytokine family, and tested at 100 ng/mL. Signals were interpolated on the assay standard curve to interpolate concentrations. The assay is human specific, as mouse IL15 cytokine was not detected using this assay.

The possible interference from human Interleukin 15 Receptor alpha / Fc Chimera (IL15 Rα) was investigated. No interference was observed up to 50 ng/mL for IL15 Rα.

Tested protein

Cross reactivity

Human IL-15

100%

Human IL-2

0%

Human IL-21

0%

Mouse IL-15

0%

Tested protein

Interference

IL-15R-Fc

No interference

 

Assay validation

Modulation of secretion of human IL-15 in NCI-H2172 cell line

NCI-H2172 cells plated at 50 kcells/well were stimulated for 48 h with PMA 10 ng/mL, IFN Ɣ 10 ng/mL, or with both compounds for 48H. 16 µL of supernatants were then transferred into a white detection plate (384 low volume) to be analyzed with the Human IL-15 Assay. As expected, treatment with PMA and IFNƔ induced IL-15 production and secretion (IFN-γ Induces IL-15 Trans-Presentation by Epithelial Cells via IRF1 J Immunol (2022) 208 (2): 338–346.)

Validation of HTRF Human Human IL15 kit on NCI-H2172 Cell line
Validation of HTRF human IL-15 kit on HUT-102 cell line

HUT-102 human cutaneous T cell lymphocyte cells were cultured at a cell density of 2x106 cells/mL in RPMI medium with 10% FBS for 24H at 37°C for supernatant generation to be analyzed by the Human IL-15 HTRF assay. The IL-15 concentration in HUT-102 cell supernatant was 153 pg/mL. These results are in accordance with the literature (Blood (1998) 91 (11): 4265–4272).

assay-validation-IL15-62HIL15PEG-62HIL15PEH-62HIL15PEJ-02.png
Interference with IL-15 receptor

The HTRF human IL-15 assay is able to detect monomeric IL-15 in presence of a large excess of IL-15 Receptor.

assay-validation-IL15-62HIL15PEG-62HIL15PEH-62HIL15PEJ-03_1080.png

 

Resources

Are you looking for resources, click on the resource type to explore further.

1-1 of 1 Resources
Brochure Icon
Brochure
HTRF assays and reagents catalog

Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...

Scroll Icon